home about animi-3 Skip Navigation Links
deficienciesExpand deficiencies
healthcare professionals research contact
 
Arthritis
Cardiovascular
Depression
Diabetes
Pregnancy
Alcohol Consumption

     

Deficiences

People with rheumatoid arthritis, cardiovascular disease, dementia, diabetes or depression often have a deficiency in omega-3 fatty acids and essential B vitamins including folic acid.

The question of which came first, the disease or the deficiency, has no clear answer. Do these diseases contribute to deficiencies or do insufficient dietary intakes of these essential nutrients lead to the onset and deterioration associated with these diseases?

Statistics confirm that Americans have the lowest intake of essential omega-3 fatty acids of any developed country. DHA, the omega-3 that is present in every cell membrane of the human body and highly concentrated in the brain, retina of the eye and the heart, is vital to good health.

According to Dr. Barbara Levine, associate professor of nutrition in clinical medicine at Weill Cornell Medical College and director of the DHA Information Center at New York-Presbyterian/Weill Cornell:

"Increasing the intake of omega-3 fatty acids, including DHA and EPA, has been clinically shown to often reduce severity of these diseases, so that patients are able to reduce or eliminate medications that have serious side effects."

Dr. Levine is an expert on nutritional interactions between genetics and the prevention of cardiovascular disease, diabetes, and cancer, as well as the optimal diet for cognitive function and visual acuity in young children.

The risk of heart disease is often linked to an increase in homocysteine levels, which is a risk factor for other disease states. Homocysteine is an amino acid in the blood stream that can be measured by a physician and may help predict some diseases.

Read more about omega-3 (DHA & EPA), folic acid, vitamins B6 and B12 conditional deficiencies in:

----------------------------------------------------

FDA “Qualified Health Claims” Omega-3 Fatty Acids & Coronary Heart Disease. Consumption of omega-3 fatty acids may reduce the risk of coronary heart disease. FDA evaluated the above claim and determined that, although there is scientific evidence supporting the claim, the evidence is not conclusive. Docket No. 9IN-0103. 

FDA “Qualified Health Claims” B vitamins & Vascular Disease. As part of a well-balanced diet that is low in saturated fat and cholesterol, Folic Acid, Vitamin B6 and Vitamin B12 may reduce the risk of vascular disease. FDA evaluated the above claim and found that, while it is known that diets low in saturated fat and cholesterol reduce the risk of heart disease and other vascular diseases, the evidence in support of the above claim is inconclusive. Docket No. 99P-3029.
 

Prescribing Info Side Effects Free Voucher Availability Press Room PBM Pharmaceuticals


Animi-3 is indicated for improving nutritional status in conditions requiring DHA, Vitamin B12, B6, and folic acid supplementation.
Animi-3 is not intended to diagnose, treat, or cure any disease.